Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin.
Gill PS, Espina BM, Muggia F, Cabriales S, Tulpule A, Esplin JA, Liebman HA, Forssen E, Ross ME, Levine AM.
Gill PS, et al. Among authors: tulpule a.
J Clin Oncol. 1995 Apr;13(4):996-1003. doi: 10.1200/JCO.1995.13.4.996.
J Clin Oncol. 1995.
PMID: 7707129
Clinical Trial.